Emerging Strategies to Access Peptide Macrocycles from Genetically Encoded Polypeptides
The Journal of Organic Chemistry2013Vol. 78(8), pp. 3525–3531
Citations Over TimeTop 10% of 2013 papers
Abstract
Macrocyclic peptides have emerged as attractive molecular scaffolds for the development of chemical probes and therapeutics. In this synopsis, we highlight contemporary strategies to access peptide macrocycles from ribosomally produced polypeptides. Challenges that have been tackled in this area involve orchestrating the desired macrocyclization process in the presence of unprotected polypeptide precursors and expanding the functional space encompassed by these molecules beyond that of canonical amino acid structures. Applications of these methodologies for the discovery of bioactive molecules are also discussed.
Related Papers
- → Fragment‐based drug discovery—the importance of high‐quality molecule libraries(2022)129 cited
- → Antibody-enabled small-molecule drug discovery(2012)79 cited
- → Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (CyreneTM)(2023)10 cited
- → Fragment-based screening with natural products for novel anti-parasitic disease drug discovery(2019)27 cited
- → Synthetic Macrocycles in Small-Molecule Drug Discovery(2013)24 cited